Abstract
THE discovery1, in 1955, of a hereditary myopathy in a strain of mice has provided a useful subject for the investigation of muscular dystrophy. Although the ultimate cause of the mouse disease may not be identical with the cause of any of the human muscular dystrophies, it is a reasonable assumption that many of the secondary changes will be similar. A number of workers have reported quantitative enzyme changes in the dystrophic mouse muscle. Some activities, for example, cathepsins2 and glucose-6-phosphate dehydrogenase3, show an increase; others, for example, lactic dehydrogenase4 and phosphorylase5, are decreased.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Michelson, A. M., Russell, E. S., and Harman, P. J., Proc. U.S. Nat. Acad. Sci., 41, 1079 (1955).
Weinstock, I. M., Epstein, S., and Milhorat, A. T., Proc. Soc. Exp. Biol. N.Y., 99, 272 (1958).
McCaman, M. W., Science, 132, 621 (1960).
White, L. P., Calif. Med., 90, 1 (1959).
Leonard, S. L., Proc. Soc. Exp. Biol., N.Y., 96, 720 (1957).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
PENNINGTON, R. 5′-Adenylic Acid Deaminase in Dystrophic Mouse Muscle. Nature 192, 884–885 (1961). https://doi.org/10.1038/192884a0
Issue Date:
DOI: https://doi.org/10.1038/192884a0
- Springer Nature Limited